AMAL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMAL is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is near fair value with neutral-to-mixed technicals, no strong proprietary buy signal, and options sentiment that leans bearish. While the latest quarter shows solid revenue growth and modest EPS improvement, the market is not giving a clear momentum or sentiment edge. My direct view: hold and wait for a better entry rather than buying immediately.
Price closed at 41.96, slightly above the pivot at 41.152 and below resistance at R1 42.371. RSI_6 at 59.565 is neutral-to-slightly constructive, but MACD histogram is -0.104 and still below zero, showing momentum is not fully bullish. Moving averages are converging, which points to a lack of trend conviction. The short-term pattern data also looks weak, with a 70% chance of -1.1% next day and a negative expected move over the next month. Overall, the current trend is sideways to mildly weak, not an attractive chase-buy setup.
["Q1 2026 revenue rose 16.68% YoY to 84,555,000.", "EPS increased 3.70% YoY to 0.84, showing modest earnings growth.", "Analysts recently raised price targets to $44 and $48.", "Piper Sandler noted stronger deposit growth and better PPNR results.", "No negative news in the last week, so there is no immediate event-driven pressure."]
["No AI Stock Picker signal today.", "No SwingMax signal recently.", "Insiders are selling, with selling up 421.50% over the last month.", "Options positioning is heavily put-skewed.", "Credit noise was highlighted by analysts in Q1, especially around rent-regulated multifamily and consumer solar stress.", "The stock underperformed after those credit concerns.", "No recent news catalysts to drive a near-term rerating.", "Similar pattern analysis points to negative short-term performance."]
In Q1 2026, Amalgamated Financial reported revenue of 84,555,000, up 16.68% year over year, which is a healthy growth rate. Net income increased slightly to 25,223,000, up 0.78% YoY, and EPS rose 3.70% YoY to 0.84. This shows the company is still growing, but profit growth is much slower than revenue growth, so the latest quarter was decent rather than strong. For a long-term beginner investor, this is acceptable fundamental progress, but not strong enough to justify an aggressive immediate buy.
Analyst sentiment is mixed but improving. Piper Sandler raised its price target to $44 from $41 and kept a Neutral rating, citing strong deposit growth and better PPNR, while Keefe Bruyette raised its target to $48 from $43 and kept an Outperform rating. Earlier, Piper Sandler initiated coverage at Neutral with a $41 target, mentioning a good return profile but some credit improvement needed. The pros view is that the bank has a solid return story and improving operating performance; the cons view is ongoing credit concerns and prior underperformance. Overall, Wall Street is constructive but not uniformly bullish.
